Stay updated on Upadacitinib vs Methotrexate in RA Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib vs Methotrexate in RA Clinical Trial page.

Latest updates to the Upadacitinib vs Methotrexate in RA Clinical Trial page
- Check3 days agoChange DetectedThe page adds a 2015 U.S. NIH Grant/Contract funding line and removes related-topic entries including Rheumatoid arthritis and MedlinePlus Genetics from the related topics section, altering funding disclosure and topic associations.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRevision: v3.6.5 replaces the previous v3.6.4. This reflects a minor system update to the page.SummaryDifference0.0%

- Check25 days agoChange DetectedThe page adds related topic links for rheumatoid arthritis and MedlinePlus Genetics, connecting the study to broader background information on the condition and genetics.SummaryDifference0.1%

- Check32 days agoChange DetectedThe revision stamp on the page was updated from v3.6.3 to v3.6.4, indicating a small internal update to the page's documentation/versioning. This update does not affect visible content.SummaryDifference0.0%

- Check39 days agoChange DetectedThe page no longer displays the Disease tag 'Rheumatoid arthritis' and the related topics section, including the MedlinePlus Genetics link. This changes how users navigate to disease-related topics but does not alter the study details presented.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3 to reflect a minor update to the page's documentation/version history.SummaryDifference0.0%

Stay in the know with updates to Upadacitinib vs Methotrexate in RA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Methotrexate in RA Clinical Trial page.